Hitesh Kumar Maheshwari joins Ipca Labs as President - RnD (Formulations)

Published On 2023-10-17 08:00 GMT   |   Update On 2023-10-17 08:01 GMT
Advertisement

Mumbai: Ipca Labs has appointed Hitesh Kumar Maheshwari as President – R&D (Formulations) with effect from 16th October, 2023. 

"He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the Company," Ipca Labs informed in a BSE filing.

Hitesh Maheshwari, aged 49 years has completed his B. Pharm from Devi Ahilya Vishwavidyalaya, Indore and M.Pharm from Panjab University, Chandigarh. Maheshwari brings with him a professional experience of over 24 years. He started his career with Ranbaxy Laboratories in the year 1999 and thereafter worked with Zydus Cadila Healthcare Ltd., Hikma Pharmaceuticals Ltd., Astron Research Ltd. and Macleods Pharmaceuticals Ltd.

Advertisement

Prior to joining Ipca, he was associated with Torrent Pharmaceuticals Ltd. as Executive Director and Head – R&D (Formulations). 

Medical Dialogues team had earlier reported that the company's shareholders had approved the re-appointment of Pranay Godha as the Managing Director of the Company with effect from 11th November, 2023 for the period of five years till 10th November, 2028.

Read also: Ipca Labs shareholders approve re-appointment of Pranay Godha as MD

Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The Company was founded by group of businessmen and medical professionals in 1949. It produces theobromine, acetyl thiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. Ipca is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.

Read also: Ipca Labs buys 33.38 percent stake in Unichem for over Rs 945 crore

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News